Use of Nicotine Pouches Among Daily Smokers
Key facts
- Who runs it
- Milton S. Hershey Medical Center
- Where
- Hershey and Houston, United StatesSee the 2 sites
- Trial code
- Status
- Recruiting
- People taking part
- 375 people, planned
- Started
- 17 Sept 2024
- Expected to end
- Aug 2028
- Type of study
- Interventional, 6 groups
- Treatments tested
- 0 mg nicotine pouch
- 3 mg nicotine pouch
- 6 mg nicotine pouch
- Smooth nicotine pouch
- Wintergreen nicotine pouch
- Record updated
- 20 October 2026
Who can take part
- Age
- 21 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Commonly smoke ≥ 5 cigarettes per day (at least 2 days/week) for at least the prior 12 months
- Exhaled CO measurement of ≥ 6 parts per million at baseline
- Must be interested in reducing cigarette consumption by at least 50% and willing to try nicotine pouches
- Able to understand, read and write in English
- Access to e-mail and a smartphone/computer that has reliable internet connection
- Able to understand and give informed consent
Who cannot take part
- Recent (past 3 months) unstable illness that may increase risks of participation or ability to participate fully (e.g. hospitalization for a mental health condition or substance use disorder in prior 6 months, stroke or myocardial infarction in the past year)
- Use of illegal drugs daily or weekly in the past 3 months
- Serious current respiratory diseases (e.g. exacerbations of asthma or chronic obstructive pulmonary disease [COPD], requiring oxygen or oral prednisone), kidney disease (e.g. requiring dialysis), liver disease (e.g cirrhosis), or any medical disorder/medication that may affect participant safety or biomarker data
- Any other condition that in the opinion of the investigator would make it unlikely that the participant could comply with the study protocol
- Plans to quit smoking within the next 30 days
- Currently pregnant, breastfeeding, or planning to become pregnant in the next 6 months
- Use of a nicotine pouch or other non-cigarette nicotine product (e-cigarette, pipe, cigar, chew, snus, hookah, IQOS) for 5 or more days in the past 28 days
- Use of combustible (smoked) recreational or medical marijuana weekly in the past 3 months (less frequent smoked medical marijuana or use of other forms of medical marijuana are ok)
- Other member of the household currently participating in the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 70 years old?
Where in United States
- Penn State College of MedicineHershey, United StatesContact: Nicolle M Krebs, MSTaking people
- University of Texas - MD Anderson Cancer CenterHouston, United StatesContact: Jason Robinson, PhDTaking people
About the trial
What the trial wants to find out
The purpose of this clinical trial is to understand the health effects of a new oral nicotine pouch, and also to understand if this product can help reduce traditional cigarette smoking. The main aims are:
Read full original descriptionShow less
1. Understand the impact of nicotine pouch use on toxicant exposure biomarkers, and indicators of potential harms to health. 2. Examine the influence of nicotine pouch use on conventional tobacco product use (cigarettes).
Participants will be randomized to one of six nicotine pouch groups (3 nicotine strengths, each with 2 potential flavors) to use over 16 weeks and asked to reduce their cigarette smoking over that time by at least 75% by substituting with the use of the nicotine pouches. Researchers will compare the outcomes of the different nicotine pouch strengths and flavors to each other. Participants will be asked to complete study questionnaires and provide urine, exhaled carbon monoxide, and mouth cell samples, and other health measurements.
The 6 groups in the trial
- 0 mg + Smooth flavorTreatment being tested
Participants are provided with zero strength (0 mg) nicotine pouches with smooth flavor.
Treatment: 0 mg nicotine pouch and Smooth nicotine pouch
- 3 mg + Smooth flavorTreatment being tested
Participants are provided with medium strength (3 mg) nicotine pouches with smooth flavor.
Treatment: 3 mg nicotine pouch and Smooth nicotine pouch
- 6 mg + Smooth flavorTreatment being tested
Participants are provided with high strength (6 mg) nicotine pouches with smooth flavor.
Treatment: 6 mg nicotine pouch and Smooth nicotine pouch
- 0 mg + Wintergreen flavorTreatment being tested
Participants are provided with zero strength (0 mg) nicotine pouches with wintergreen flavor.
Treatment: 0 mg nicotine pouch and Wintergreen nicotine pouch
- 3 mg + Wintergreen flavorTreatment being tested
Participants are provided with medium strength (3 mg) nicotine pouches with wintergreen flavor.
Treatment: 3 mg nicotine pouch and Wintergreen nicotine pouch
- 6 mg + Wintergreen flavorTreatment being tested
Participants are provided with high strength (6 mg) nicotine pouches with wintergreen flavor.
Treatment: 6 mg nicotine pouch and Wintergreen nicotine pouch
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Randomized Placebo-controlled Trial of Nicotine Pouches in Smokers
- Fit questions
- Built from NCT06043362, who can take part
- Record updated
- 20 October 2026